The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis

H Nagase, S Ueki, S Fujieda - Allergology International, 2020 - jstage.jst.go.jp
abstract IL-5 is the most potent activator of eosinophils and is produced by Th2 cells and
ILC2s. A role for IL-5 in eosinophil extracellular trap cell death, ie, a proinflammatory cell …

Dupilumab: Basic aspects and applications to allergic diseases

K Matsunaga, N Katoh, S Fujieda, K Izuhara… - Allergology …, 2020 - jstage.jst.go.jp
abstract Interleukin (IL)-4 and IL-13, signature type 2 cytokines, exert their actions by binding
to two types of receptors sharing the IL-4R a chain (IL-4Ra). Since IL-4 and IL-13 play …

[HTML][HTML] Long-term therapy response to anti–IL-5 biologics in severe asthma—a real-life evaluation

K Eger, JA Kroes, A Ten Brinke, EH Bel - The Journal of Allergy and …, 2021 - Elsevier
Background Patients with severe eosinophilic asthma show different responses to various
anti–IL-5 biologics, ranging from super response to nonresponse. Residual disease …

The severe asthma network in Italy: findings and perspectives

E Heffler, F Blasi, M Latorre, F Menzella… - The Journal of Allergy …, 2019 - Elsevier
Background Severe Asthma Network in Italy (SANI) is a registry of patients recruited by
accredited centers on severe asthma. Objective To analyze epidemiological, clinical …

Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): a randomized double‐blind placebo‐controlled trial

J Tversky, AP Lane, A Azar - Clinical & Experimental Allergy, 2021 - Wiley Online Library
Background Chronic rhinosinusitis with nasal polyps (CRSwNP) can be a severe and
debilitating disease associated with significant morbidity, loss of smell, sinus pressure and …

European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis

P Gevaert, J De Craemer, C Bachert, M Blauwblomme… - Allergy, 2023 - Wiley Online Library
Nasal endoscopy is not only used for the diagnosis of chronic rhinosinusitis with nasal
polyps (CRSwNP), but also for monitoring the response to therapy playing an important role …

Endotypes of chronic rhinosinusitis with nasal polyps: pathology and possible therapeutic implications

C Bachert, B Marple, W Hosemann, C Cavaliere… - The Journal of Allergy …, 2020 - Elsevier
Today, chronic rhinosinusitis (CRS) is a symptomatic disease diagnosed by nasal
endoscopy and eventually computed tomography scan, and is treated by pharmacotherapy …

[HTML][HTML] Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: evidences from the Severe Asthma Network Italy (SANI) registry

GW Canonica, L Malvezzi, F Blasi, P Paggiaro… - Respiratory …, 2020 - Elsevier
Background The clinical and laboratory features of patients enrolled in the Severe Asthma
Network in Italy (SANI) registry, a web-based observatory collecting demographic, clinical …

Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities

M Koennecke, L Klimek, J Mullol, P Gevaert… - Allergo journal …, 2018 - Springer
Background Chronic rhinosinusitis (CRS) is a heterogeneous, multifactorial inflammatory
disease of the nasal and paranasal mucosa. It has not been possible to date to develop an …

Therapeutic strategies of biologics in chronic rhinosinusitis: current options and future targets

J Tai, M Han, TH Kim - International journal of molecular sciences, 2022 - mdpi.com
Chronic rhinosinusitis is a chronic inflammatory disease of the upper airways, for which
treatment options include medical or surgical therapy. However, there are limitations to …